Use of donor lymphocyte infusions (DLI) for the treatment of relapse after allogeneic bone marrow transplantation (ABMT): Effective GVT in chronic myeloid leukemia (CML) with no clinical GVHD.

被引：0

作者：

Hahn, TE ^{[1
]}

Alam, AR ^{[1
]}

Miller, A ^{[1
]}

Meteer, J ^{[1
]}

Dascomb, S ^{[1
]}

Baer, MR ^{[1
]}

Bambach, B ^{[1
]}

Bernstein, S ^{[1
]}

Bernstein, Z ^{[1
]}

Chanan-Khan, A ^{[1
]}

Czuczman, M ^{[1
]}

Slack, J ^{[1
]}

Wetzler, M ^{[1
]}

Becker, J ^{[1
]}

Stewart, C ^{[1
]}

McCarthy, PL ^{[1
]}

机构：

[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA

来源：

BLOOD | 2001年 / 98卷 / 11期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

5239

引用

页码：366B / 366B

页数：1

共 50 条

[1] Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation
A Bacigalupo
M Soracco
F Vassallo
M Abate
MT Van Lint
F Gualandi
T Lamparelli
D Occhini
N Mordini
S Bregante
O Figari
F Benvenuto
M Sessarego
G Fugazza
P Carlier
M Valbonesi
Bone Marrow Transplantation, 1997, 19 : 927 - 932
[2] Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation
Bacigalupo, A
Soracco, M
Vassallo, F
Abate, M
VanLint, MT
Gualandi, F
Lamparelli, T
Occhini, D
Mordini, N
Bregante, S
Figari, O
Benvenuto, F
Sessarego, M
Fugazza, G
Carlier, P
Valbonesi, M
BONE MARROW TRANSPLANTATION, 1997, 19 (09) : 927 - 932
[3] Donor leukocyte infusions (DLI) to treat leukemia relapse after allogeneic bone marrow transplantation (aloBMT).
Reynoso, EE
Guevara, AG
Miranda, E
Salinas, V
Acosta, A
Sobrevilla, PJ
BLOOD, 1995, 86 (10) : 3835 - 3835
[4] DONOR LEUKOCYTE INFUSIONS FOR CHRONIC MYELOID-LEUKEMIA IN RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
CULLIS, JO
JIANG, YZ
SCHWARER, AP
HUGHES, TP
BARRETT, AJ
GOLDMAN, JM
BLOOD, 1992, 79 (05) : 1379 - 1381
[5] Donor lymphocyte infusions (DLI) for relapse after allogeneic bone marrow transplantation (BMT).: Hematologic, cytogenetic and molecular results
Thiébaut, A
Michallet, M
Gebuhrer, L
Lasne, Y
Charrin, C
Mollet, I
Belhabri, A
Archimbaud, E
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 322 - 322
[6] Donor leukocyte infusions in the treatment of chronic myeloid leukemia in relapse post bone marrow transplantation
Hill, GR
Hart, DNJ
Moore, AF
Morris, CM
PATHOLOGY, 1996, 28 (01) : 51 - 53
[7] Donor lymphocyte infusions (DLI) for relapse after allogeneic bone marrow transplantation (BMT). Hematologic, cytogenetic and molecular results.
Thiebaut, A
Michallet, M
Gebuhrer, L
Lasne, Y
Charrin, C
Mollet, I
Belhabri, A
Archimbaud, E
BONE MARROW TRANSPLANTATION, 1998, 21 : S66 - S66
[8] Donor lymphocyte infusions (DLI) for treatment of CML in relapse after allogeneic BMT: Low incidence of GVHD using an escalation dose protocol.
Olavarria, E
Dazzi, F
Craddock, C
Murphy, KM
Philpott, NJ
Kanfer, E
Apperley, JF
Goldman, JM
BLOOD, 1997, 90 (10) : 2621 - 2621
[9] Toxicity and efficacy of 409 donor lymphocyte infusions for treatment of relapse after allogeneic bone marrow transplantation
Raiola, AM
Van Lint, MT
Lamparelli, T
Gualandi, F
Di Grazia, C
Dominietto, A
Romagnani, C
Berisso, G
Bregante, S
Vassallo, F
Frassoni, F
Bacigalupo, A
BONE MARROW TRANSPLANTATION, 2001, 27 : S127 - S127
[10] Donor lymphocyte infusions for the treatment of chronic myeloid leukemia relapse following peripheral blood or bone marrow stem cell transplantation
G W Basak
L C de Wreede
A van Biezen
W Wiktor-Jedrzejczak
K Halaburda
C Schmid
N Schaap
F Dazzi
P A von dem Borne
E Petersen
D Beelen
A Abayomi
L Volin
A Buzyn
G Gurman
D Bunjes
C Guglielmi
E Olavarria
T de Witte
Bone Marrow Transplantation, 2013, 48 : 837 - 842

← 1 2 3 4 5 →